Related Experiment Video
Updated: Jan 27, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms
1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Sungkyunkwan University, Seoul, Republic of Korea.
Insights
Statins, cholesterol-lowering drugs, show promise in preventing and treating liver cancer (hepatocellular carcinoma). Further research is needed to confirm their effectiveness in clinical trials.
Area of Science:
- Pharmacology
- Oncology
- Hepatology
Background:
- Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are primarily used for hypercholesterolemia and cardiovascular disease prevention.
- They function by inhibiting HMG-CoA reductase, a key enzyme in cholesterol synthesis, and influencing the mevalonate pathway.
Purpose of the Study:
- To explore the potential antitumor effects of statins in hepatocellular carcinoma (HCC).
- To review existing evidence on statins' role in HCC prevention and treatment.
Main Methods:
- Review of observational and experimental studies investigating statins' effects on HCC.
- Analysis of mechanisms underlying statins' antitumor properties, including mevalonate pathway modulation.
Main Results:
- Statins exhibit antitumor properties such as proapoptotic, antiproliferative, anti-inflammatory, and antifibrotic effects.
- These effects are linked to both mevalonate pathway-mediated and non-mevalonate pathway-mediated mechanisms.
- Statins also contribute to improved metabolic status and endothelial function.
Conclusions:
- Statins represent a potential novel approach for HCC prevention and treatment due to their diverse biological activities.
- While promising, further prospective interventional studies and randomized controlled trials are necessary to validate these findings.
Abstract:
Statins, or 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, are widely used to treat hypercholesterolemia for primary and secondary prevention of cardiovascular disease. Statins inhibit HMG-CoA reductase, the rate-limiting step in cholesterol synthesis, and modulate the downstream signaling of the mevalonate pathway. In addition to the primary effect, the antitumor effect of statins can be associated with mevalonate pathway-mediated and nonmevalonate pathway-mediated mechanisms, which improve endothelial function and lead to proapoptotic, antiproliferative, antiinflammatory, and antifibrotic properties. Statins are implicated in the improvement of metabolic status. Statins are orally available and safely and widely used for long-term treatment; they represent a novel approach for the prevention and treatment for hepatocellular carcinoma (HCC). Although several observational studies and experimental studies have revealed the preventive and therapeutic potential of statins for HCC treatment, further prospective interventional studies and randomized control trials are warranted to confirm these observations.
Related Concept Videos
The Evidence for Evolution
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

